FIELD: organic chemistry, proteins, biochemistry. SUBSTANCE: invention describes peptide of the formula: Asp-Glu-Asn-Pro-Val-Val-His-Phe-Phe-Lys-Asn-Ile-Val-Thr- - Pro-Arg-Thr that is able to neutralize or modulate formation of antimyelin basic protein. Peptide can be used for treatment of patients with cerebrospinal sclerosis and it exhibits the more activity as compared with that of myelin basic protein. Peptide does not exhibit toxicity and immunogenic properties. Invention describes also pharmaceutical composition comprising peptide and method of treatment of patients with cerebrospinal sclerosis. EFFECT: improved method of treatment, valuable medicinal properties of peptide and composition. 8 cl, 4 tbl, 35 dwg, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE SPECIFICITY OF ANTIBODY TO MYELIN BASIC PROTEIN, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF AND METHOD OF TREATMENT OF PATIENTS WITH CEREBROSPINAL SCLEROSIS | 1995 |
|
RU2157815C2 |
| PHARMACEUTICAL COMPOSITION AND A METHOD OF TREATMENT OF PATIENTS WITH CEREBROSPINAL SCLEROSIS | 1992 |
|
RU2121850C1 |
| METHOD OF TREATING MULTIPLE SCLEROSIS | 2005 |
|
RU2384345C2 |
| LIPOSOMES CONTAINING OLIGOPEPTIDES - FRAGMENTS OF MYELIN BASIC PROTEIN, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING MULTIPLE SCLEROSIS | 2009 |
|
RU2448685C2 |
| PEPTIDE FROM THE COMPOSITION OF THE IMMUNOGLOBULIN HUMAN HEAVY CHAIN, SUITABLE FOR TREATMENT OF MULTIPLE SCLEROSIS | 2016 |
|
RU2646817C1 |
| METHOD FOR TREATING MULTIPLE SCLEROSIS | 2015 |
|
RU2757961C2 |
| PEPTOID LIGANDS FOR AUTOIMMUNE T-CELL RECOVERY AND PROCESSING | 2010 |
|
RU2563822C2 |
| COMPOSITIONS FOR TREATMENT OF DISSEMINATED SCLEROSIS | 2008 |
|
RU2492234C2 |
| T-CELLULAR VACCINE FOR CEREBROSPINAL SCLEROSIS TREATMENT | 1998 |
|
RU2209633C2 |
| THERAPY OF INFLAMMATORY DISEASES | 2007 |
|
RU2440110C2 |
